Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMinor layout/formatting adjustments on the Study Details page; no changes to eligibility criteria, interventions, primary or secondary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedAdded a government funding notice and updated version to v3.2.0; removed the term ‘Small cell lung carcinoma’ and reference to v3.1.0.SummaryDifference2%

- Check47 days agoChange DetectedUpdate term from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and bump version from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page revision was bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%

- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as a range of cancer-related topics and resources. Notably, the revision number has been updated to v3.0.0.SummaryDifference5%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.